To investigate whether K-RAS/ERK axis was involved in this mechanism in irradiated-GBM cells, we treated the ERK inhibitor, U0126 (10 μM), for 24 h into irradiated-U87MG cells to perform the invasion and migration assay and FACS analysis and sphere formation assay. This evidence concerns the gene KRAS and glioblastoma.